Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel × Prednisone × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 36 Lymphoma, Large B-Cell, Diffuse 22 Burkitt Lymphoma 15 Lymphoma 14 Lymphoma, Follicular 11 Neoplasms 8 Lymphoma, Non-Hodgkin 7 Prostatic Neoplasms, Castration-Resistant 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Lymphoma, B-Cell 4 Recurrence 3 Myasthenia Gravis 3 Lymphoma, Mantle-Cell 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Biphenotypic, Acute 3 Hodgkin Disease 3 Waldenstrom Macroglobulinemia 2 Skin Neoplasms 2 Neoplasms, Plasma Cell 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Melanoma 2 Lymphoma, T-Cell, Peripheral 2 Leukemia 2 Hematologic Neoplasms 2 Colitis 2 Carcinoma, Non-Small-Cell Lung 2 Vasculitis, Central Nervous System 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡